Delva Shamley

8PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersAboriginal and Torres Strait Islander medicine and treatmentsFoetal development and medicinePharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 27, 2026
Genetic Variation in <i>CYP2B6</i>, <i>UGT1A4</i> and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen.

|Mar 28, 2026
<i>SULT</i> and <i>UGT</i> Genetic Variants Modulate Side Effect Profiles in South African Breast Cancer Patients Treated with Tamoxifen.

Bianca Kruger, Emile Chimusa, Aron Abera

|Mar 13, 2024
Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data.

Bianca Kruger, Delva Shamley, Nyarai Desiree Soko

|Aug 25, 2023
Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases.

Nyarai Desiree Soko, Sarudzai Muyambo, Michelle T L Dandara

|Jan 21, 2023
Polymorphisms in <i>COMT</i> and <i>OPRM1</i> Collectively Contribute to Chronic Shoulder Pain and Disability in South African Breast Cancer Survivors'.

Firzana Firfirey, Delva Shamley, Alison V September

|Jun 21, 2022
<i>ABCB1</i> and <i>OPRM1</i> single-nucleotide polymorphisms collectively modulate chronic shoulder pain and dysfunction in South African breast cancer survivors.

Firzana Firfirey, Alison V September, Delva Shamley

Pageof 2

Frequent Collaborators

4 joint publications

Collet Dandara

3 joint publications

Bianca Kruger

2 joint publications

Firzana Firfirey

2 joint publications

Nyarai Desiree Soko